Literature DB >> 30049544

Viral hepatitis: "E" is for equitable elimination.

Jeffrey V Lazarus1, Juan M Pericàs2, Massimo Colombo3, Michael Ninburg4, Stefan Wiktor5, Mark Thursz6.   

Abstract

Entities:  

Keywords:  Hepatitis C; Viral hepatitis policy

Mesh：

Year:  2018        PMID： 30049544     DOI： 10.1016/j.jhep.2018.06.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid.

Authors:  José Luis Calleja; Javier García-Samaniego; Jeffrey V Lazarus; Marcela Villota-Rivas; Inmaculada Fernández; Francisco Gea; Pablo Ryan; Sonia Alonso López; Danielle Guy
Journal:  Commun Med (Lond)       Date:  2022-02-24

2.  Hepatitis C services at harm reduction centres in the European Union: a 28-country survey.

Authors:  Juan M Pericàs; Daniel J Bromberg; Denise Ocampo; Eberhard Schatz; Iwona Wawer; Piotr Wysocki; Kelly Safreed-Harmon; Jeffrey V Lazarus
Journal:  Harm Reduct J       Date:  2019-03-21

3.  The Copenhagen test and treat hepatitis C in a mobile clinic study: a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T'N'T HepC).

Authors:  Jeffrey Victor Lazarus; Anne Øvrehus; Jonas Demant; Louise Krohn-Dehli; Nina Weis
Journal:  BMJ Open       Date:  2020-11-09       Impact factor: 2.692

4.  Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study.

Authors:  Arantza Sanvisens; Inmaculada Rivas; Eva Faure; Néstor Espinach; Anna Hernandez-Rubio; Xavier Majó; Joan Colom; Robert Muga
Journal:  World J Gastroenterol       Date:  2020-10-14       Impact factor: 5.742

5.  Meet-Test-Treat for HCV management: patients' and clinicians' preferences in hospital and drug addiction services in Italy.

Authors:  Massimo Andreoni; Nicola Coppola; Antonio Craxì; Stefano Fagiuoli; Ivan Gardini; Alessandra Mangia; Felice Alfonso Nava; Patrizio Pasqualetti
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.